Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Breast Cancer Research : BCR
Timothy R Rebbeck, Susan Domchek

Abstract

Genetic testing for BRCA1 and BRCA2 (BRCA1/2) mutations can provide important information for women who are concerned about their breast and ovarian cancer risks and need to make relevant prevention and medical management decisions. However, lifetime risks of breast cancer in individual BRCA1/2 mutation carriers have been confusing to apply in clinical decision-making. Published risk estimates vary significantly and are very dependent on the characteristics of the population under study. Recently, Begg and colleagues estimated cancer risks in a population-based study of BRCA1/2 mutation carriers. Here, we discuss the clinical decision-making implications of this research in the context of risk factors that may influence risk estimates in BRCA1/2 mutation carriers.

References

Apr 10, 1995·American Journal of Medical Genetics·M J SellerG S Tint
May 30, 1998·Journal of the National Cancer Institute·J S BrunetS A Narod
May 25, 2002·The New England Journal of Medicine·Timothy R RebbeckUNKNOWN Prevention and Observation of Surgical End Points Study Group
Sep 19, 2002·Journal of the National Cancer Institute·Marcia S BroseBarbara L Weber
Oct 25, 2003·Science·Mary-Claire KingUNKNOWN New York Breast Cancer Study Group
Apr 20, 2004·International Journal of Cancer. Journal International Du Cancer·Parviz GhadirianSteven A Narod
Jul 21, 2005·International Journal of Cancer. Journal International Du Cancer·André NkondjockSteven A Narod
Sep 8, 2005·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Oct 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy R RebbeckUNKNOWN PROSE Study Group
Oct 26, 2005·Carcinogenesis·Susan ColillaTimothy R Rebbeck
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joan L KramerMark H Greene
Feb 24, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jennifer S LeeAlice S Whittemore
Apr 20, 2006·Journal of the National Cancer Institute·Nadine AndrieuUNKNOWN IBCCS Collaborators Group
Dec 26, 2006·Breast Cancer Research : BCR·Antonis C AntoniouD Gareth Evans
Apr 10, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jenny Chang-ClaudeUNKNOWN International BRCA1/2 Carrier Cohort Study (IBCCS) collaborators group
May 16, 2007·Cancer·Karin B MichelsKirsten B Moysich
Jul 14, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Fergus J CouchUNKNOWN Consortium of Investigators of Modifiers of BRCA1/2
Jul 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard M BrohetMatti A Rookus
Sep 15, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Rebecca TroisiRobert N Hoover
Nov 6, 2007·Clinical Obstetrics and Gynecology·Jessica Kiley, Cassing Hammond
Nov 14, 2007·American Journal of Human Genetics·Antonis C AntoniouUNKNOWN Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Jan 10, 2008·JAMA : the Journal of the American Medical Association·Colin B BeggJonine L Bernstein
Jan 15, 2008·Breast Cancer Research : BCR·Celine M VachonV Shane Pankratz
Mar 22, 2008·American Journal of Human Genetics·Antonis C AntoniouUNKNOWN CIMBA

❮ Previous
Next ❯

Citations

Jul 21, 2010·Breast Cancer Research and Treatment·Victor R GrannAlfred I Neugut
Oct 8, 2014·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Stamatia DestounisRenee Morgan
Nov 19, 2015·Nature·Moises Velasquez-Manoff
Oct 30, 2013·Gut·Rebecca C FitzgeraldUNKNOWN British Society of Gastroenterology
Sep 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Banu ArunConstance Albarracin
May 12, 2020·The Journal of Cell Biology·Haohui DuanShailja Pathania
May 14, 2020·F1000Research·James Franklin, Janusz Jankowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Nature Reviews. Cancer
Olivia Fletcher, Richard S Houlston
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Noah D KauffTimothy R Rebbeck
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Andrew Tutt, Alan Ashworth
© 2022 Meta ULC. All rights reserved